\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ hard\\ right\\ testicle\\ enlarged\\ to\\ 7\\ centimeters\\.\ \(0\)\
\-\ labs\\:\ \(4\)\
\-\ alpha\\ fetoprotein\\:\\ 1653\\ ng\\/ml\\ \\(0\\-8\\.50\\,\\ normal\\)\ \(0\)\
\-\ beta\\ hcg\\:\\ \\<2\\.0\\ miu\\/l\\ \\(0\\-5\\.0\\,\\ normal\\)\ \(0\)\
\-\ pathology\\:\\ \\ \ \(0\)\
\-\ mixed\\ germ\\ cell\\ tumor\\,\\ 55\\%\\ yolk\\ sac\\ tumor\\ and\\ 45\\%\\ teratoma\ \(0\)\
\-\ patient\\ had\\ a\\ radical\\ orchiectomy\\ and\\ had\\ a\\ negative\\ staging\\ ct\\ of\\ the\\ chest\\,\\ abdomen\\ and\\ pelvis\\ which\\ were\\ negative\\ for\\ metastatic\\ disease\\.\ \(0\)\
\-\ superior\\ pole\\ of\\ the\\ right\\ testicle\\ demonstrates\\ microcalcifications\\.\\ \\ complex\\ heterogeneous\\ solid\\ mass\\ with\\ cysts\\ and\\ calcifications\\ in\\ the\\ right\\ testicle\\.\ \(0\)\
\-\ mixed\\ germ\\ cell\\ tumors\\ of\\ the\\ testicle\ \(0\)\
\-\ teratoma\ \(130\)\
\-\ germ\\ cell\\ tumor\ \(54\)\
\-\ 28\\ year\\ old\\ with\\ a\\ 2\\ week\\ history\\ of\\ right\\ testicular\\ swelling\\ and\\ pain\\.\\ \\ patient\\ was\\ treated\\ for\\ epididymitis\\ prior\\ to\\ evaluation\\ by\\ urology\\ after\\ refractory\\ pain\\ and\\ swelling\\.\ \(0\)\
\-\ diffuse\\ microcalcifications\\ are\\ associated\\ with\\ \\&\\#8220\\;germ\\ cell\\ malignancies\\,\\ infertility\\,\\ klinefelter\\&\\#8217\\;syndrome\\,\\ and\\ cryptochordism\\&\\#8221\\;\\ \\(brant\\)\\.\\ forty\\ percent\\ of\\ males\\ with\\ testicular\\ microlithiasis\\ have\\ associated\\ germ\\ cell\\ neoplasm\\.\\ these\\ findings\\ are\\ typically\\ bilateral\\.\\ sonographic\\ images\\ show\\ diffuse\\ but\\ irregular\\ punctate\\ echodensities\\ without\\ shadowing\\ \\(brant\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ germ\\:\\ 0\\.10835954091407007\ \(0\)\
\-\ testicle\\:\\ 0\\.09323677281215842\ \(0\)\
\-\ brant\\:\\ 0\\.06055354014069843\ \(0\)\
\-\ cell\\:\\ 0\\.05657452724464427\ \(0\)\
\-\ microcalcifications\\:\\ 0\\.05612231343733512\ \(0\)\
\-\ \\#\\:\\ 0\\.04928950910207189\ \(0\)\
\-\ \\&\\:\\ 0\\.044138057237374\ \(0\)\
\-\ 1653\\:\\ 0\\.04321332560767891\ \(0\)\
\-\ 0\\-8\\.50\\:\\ 0\\.04321332560767891\ \(0\)\
\-\ miu\\/l\\:\\ 0\\.04321332560767891\ \(0\)\
\-\ 0\\-5\\.0\\:\\ 0\\.04321332560767891\ \(0\)\
\-\ cryptochordism\\:\\ 0\\.04321332560767891\ \(0\)\
\-\ testicular\\:\\ 0\\.04298727083454102\ \(0\)\
\-\ echodensities\\:\\ 0\\.039815545310816436\ \(0\)\
\-\ teratoma\\:\\ 0\\.039168988807465305\ \(0\)\
\-\ klinefelter\\:\\ 0\\.037827971251462686\ \(0\)\
\-\ mixed\\:\\ 0\\.03679336657783854\ \(0\)\
\-\ centimeters\\:\\ 0\\.035323924076139206\ \(0\)\
\-\ forty\\:\\ 0\\.03443019095460021\ \(0\)\
\-\ fetoprotein\\:\\ 0\\.03367455036721169\ \(0\)\
\-\ 8220\\:\\ 0\\.03244261689524646\ \(0\)\
\-\ 8221\\:\\ 0\\.03244261689524646\ \(0\)\
\-\ epididymitis\\:\\ 0\\.03192614377927673\ \(0\)\
\-\ 8217\\:\\ 0\\.03192614377927673\ \(0\)\
\-\ microlithiasis\\:\\ 0\\.02993856971992298\ \(0\)\
\-\ \\;\\:\\ 0\\.029785605712538143\ \(0\)\
\-\ tumor\\:\\ 0\\.02929753384721781\ \(0\)\
\-\ beta\\:\\ 0\\.02904483659838399\ \(0\)\
\-\ alpha\\:\\ 0\\.02806115671866756\ \(0\)\
\-\ swelling\\:\\ 0\\.02790991043118757\ \(0\)\
\-\ ng\\/ml\\:\\ 0\\.027843255921751707\ \(0\)\
\-\ \\:\\:\\ 0\\.027702814117418262\ \(0\)\
\-\ 2\\.0\\:\\ 0\\.027634630360875254\ \(0\)\
\-\ yolk\\:\\ 0\\.027434522544599497\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.02724226414678929\ \(0\)\
\-\ malignancies\\:\\ 0\\.026706973499902077\ \(0\)\
\-\ radical\\:\\ 0\\.026224424123366525\ \(0\)\
\-\ urology\\:\\ 0\\.025927244604658513\ \(0\)\
\-\ refractory\\:\\ 0\\.025927244604658513\ \(0\)\
\-\ infertility\\:\\ 0\\.02551274760452095\ \(0\)\
\-\ diffuse\\:\\ 0\\.02536281784681681\ \(0\)\
\-\ negative\\:\\ 0\\.0250207858958321\ \(0\)\
\-\ punctate\\:\\ 0\\.024445475624889232\ \(0\)\
\-\ staging\\:\\ 0\\.024135775126744467\ \(0\)\
\-\ males\\:\\ 0\\.024135775126744467\ \(0\)\
\-\ hcg\\:\\ 0\\.02356953548399033\ \(0\)\
\-\ hard\\:\\ 0\\.023061983136241113\ \(0\)\
\-\ percent\\:\\ 0\\.02282664382650405\ \(0\)\
\-\ shadowing\\:\\ 0\\.022249276004659035\ \(0\)\
\-\ 55\\:\\ 0\\.020307301909336235\ \(0\)\
\-\ sac\\:\\ 0\\.020307301909336235\ \(0\)\
\-\ sonographic\\:\\ 0\\.020307301909336235\ \(0\)\
\-\ associated\\:\\ 0\\.019769240803016685\ \(0\)\
\-\ 28\\:\\ 0\\.01974522882933555\ \(0\)\
\-\ \\%\\:\\ 0\\.019542363072019682\ \(0\)\
\-\ pole\\:\\ 0\\.019506061357916767\ \(0\)\
\-\ 45\\:\\ 0\\.019352862615249586\ \(0\)\
\-\ had\\:\\ 0\\.018076959012163805\ \(0\)\
\-\ right\\:\\ 0\\.01767905311981209\ \(0\)\
\-\ pathology\\:\\ 0\\.017144109951579813\ \(0\)\
\-\ complex\\:\\ 0\\.016773974890265376\ \(0\)\
\-\ solid\\:\\ 0\\.016707581629933233\ \(0\)\
\-\ irregular\\:\\ 0\\.016707581629933233\ \(0\)\
\-\ cysts\\:\\ 0\\.016409109229565524\ \(0\)\
\-\ \\<\\:\\ 0\\.01616698787991074\ \(0\)\
\-\ 7\\:\\ 0\\.016050269013765057\ \(0\)\
\-\ tumors\\:\\ 0\\.015733903714071084\ \(0\)\
\-\ calcifications\\:\\ 0\\.015574332130552707\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.015402917435269635\ \(0\)\
\-\ pelvis\\:\\ 0\\.015221036306821709\ \(0\)\
\-\ typically\\:\\ 0\\.014786400830911628\ \(0\)\
\-\ labs\\:\\ 0\\.014568500033995775\ \(0\)\
\-\ enlarged\\:\\ 0\\.014292260148941208\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01426547341133298\ \(0\)\
\-\ week\\:\\ 0\\.014225565776118766\ \(0\)\
\-\ \\(\\:\\ 0\\.014163955416546284\ \(0\)\
\-\ \\)\\:\\ 0\\.01399093513947657\ \(0\)\
\-\ superior\\:\\ 0\\.013376194593402899\ \(0\)\
\-\ normal\\:\\ 0\\.013133455437246089\ \(0\)\
\-\ show\\:\\ 0\\.012858607522017774\ \(0\)\
\-\ treated\\:\\ 0\\.012538484490607153\ \(0\)\
\-\ abdomen\\:\\ 0\\.01240874638674361\ \(0\)\
\-\ evaluation\\:\\ 0\\.012167837234445136\ \(0\)\
\-\ syndrome\\:\\ 0\\.011979934199679614\ \(0\)\
\-\ are\\:\\ 0\\.011420332083623546\ \(0\)\
\-\ these\\:\\ 0\\.010901199470381569\ \(0\)\
\-\ prior\\:\\ 0\\.01075545476569786\ \(0\)\
\-\ metastatic\\:\\ 0\\.01054465393929456\ \(0\)\
\-\ physical\\:\\ 0\\.010276986615594305\ \(0\)\
\-\ pain\\:\\ 0\\.010231452622850341\ \(0\)\
\-\ bilateral\\:\\ 0\\.01016577318291394\ \(0\)\
\-\ chest\\:\\ 0\\.010023181372830973\ \(0\)\
\-\ without\\:\\ 0\\.00986280963901059\ \(0\)\
\-\ were\\:\\ 0\\.009511207532793732\ \(0\)\
\-\ \\,\\:\\ 0\\.009289070875593195\ \(0\)\
\-\ exam\\:\\ 0\\.009202127156615383\ \(0\)\
\-\ demonstrates\\:\\ 0\\.009150103929672481\ \(0\)\
\-\ have\\:\\ 0\\.009070774893946528\ \(0\)\
\-\ 2\\:\\ 0\\.00902012008093405\ \(0\)\
\-\ but\\:\\ 0\\.008933839710948714\ \(0\)\
\-\ findings\\:\\ 0\\.008915867332303724\ \(0\)\
\-\ after\\:\\ 0\\.008666672561809816\ \(0\)\
\-\ patient\\:\\ 0\\.008397960107023412\ \(0\)\
\-\ images\\:\\ 0\\.008035607313477225\ \(0\)\
\-\ which\\:\\ 0\\.007819336211973277\ \(0\)\
\-\ for\\:\\ 0\\.007148119104340344\ \(0\)\
\-\ by\\:\\ 0\\.006974857368847425\ \(0\)\
\-\ disease\\:\\ 0\\.006846752653018157\ \(0\)\
\-\ and\\:\\ 0\\.006176779608458477\ \(0\)\
\-\ ct\\:\\ 0\\.00585933163427472\ \(0\)\
\-\ a\\:\\ 0\\.0058323500267441365\ \(0\)\
\-\ mass\\:\\ 0\\.005825789249742963\ \(0\)\
\-\ history\\:\\ 0\\.0057853653809170754\ \(0\)\
\-\ was\\:\\ 0\\.0048444976579102295\ \(0\)\
\-\ year\\:\\ 0\\.004686790535651543\ \(0\)\
\-\ old\\:\\ 0\\.00428889508265811\ \(0\)\
\-\ to\\:\\ 0\\.00418694223963712\ \(0\)\
\-\ of\\:\\ 0\\.002855485313676187\ \(0\)\
\-\ the\\:\\ 0\\.0027107702883063882\ \(0\)\
\-\ with\\:\\ 0\\.0022941995311743083\ \(0\)\
\-\ in\\:\\ 0\\.0020656726967659554\ \(0\)\
\-\ \\.\\:\\ 0\\.0017401733381052094\ \(0\)\
